Clinical trial
Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B
NCT00275938 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00275938 |
|---|---|
| Title | Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B |
| Official title | A Pilot Study Of Interferon Alpha 2b Plus Ribavirin In The Treatment Of Patients With Chronic Hepatitis B |
| Lead sponsor | National Taiwan University Hospital, Other |
| Collaborators | Schering-Plough Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | interferon alpha 2b plus ribavirin, interferon alpha 2b plus placebo |
| Enrollment | 120 |
| Start date | Oct 1, 1998 |
| Completion | Jun 1, 2001 |
| First posted | Jan 12, 2006 |
| Last update posted | Jan 12, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: